By Sarah Mirando  |  September 4, 2013

Category: Pharmaceuticals
Follow us on Twitter and Facebook for the latest Lipitor Diabetes Class Action Lawsuit & Settlement News!

 

Mississippi Woman Says Lipitor Caused Her Diabetes

By John Curran

 

Lipitor diabetes lawsuitPlaintiff Ruby Miller says in a new Lipitor lawsuit filed August 29, 2013, that she faced elevated blood sugar levels and developed type-2 diabetes as a result of undisclosed Lipitor side effects.

Miller says she began taking the medication in 2001, shortly after Pfizer Inc. bought out the company that owned the patent and new drug application for the statin medication. According to the Lipitor lawsuit, she was diagnosed with what she later found out might be Lipitor diabetes in May 2010. Women who have taken the drug reportedly had no information regarding the potential for insulin sensitivity and other problems caused by Lipitor.

Her Lipitor lawyer argues in the lawsuit that the new warning label for Lipitor, approved by the FDA in February 2012, still does not adequately warn of the risks of diabetes from Lipitor. The complaint argues that there is significant vagueness in the note that “[i]ncreases in HbA1c and fasting serum glucose levels have been reported with HMC-CoA reductase inhibitors.” Even with that, studies cited in other Lipitor diabetes lawsuits note that the risk is highest with Lipitor compared to other treatments to lower LDL cholesterol levels in the statin class.

In between Pfizer’s acquisition of Lipitor and Miller’s diagnosis of diabetes, the Lipitor lawsuit alleges that “despite its knowledge of data indicating that … use is causally related to the development of type-2 diabetes…, Pfizer promoted and marketed [its medication] as safe and effective.” As a result, the Mississippi woman’s lawsuit includes counts of failure to warn, negligence, breach of implied warranty, fraud, constructive fraud and unjust enrichment

The Lipitor type-2 diabetes side effects lawsuit is Ruby Miller v. Pfizer Inc., Case No. 13-cv-00342, U.S. District Court, Southern District of Mississippi.

A notice of pending multidistrict litigation could result in a transfer to MDL No. 2459, In re: Lipitor (Atorvastatin Calcium) Marketing, Sales Practices and Products Liability Litigation.

If you are a woman who took this statin medication and developed insulin sensitivity and related conditions, you may have legal options. Get a free consultation with a Lipitor diabetes lawsuit lawyer to assess your eligibility to file a complaint. One is available for women who fill out the short form at the Lipitor Diabetes Class Action Lawsuit Investigation today. Compensatory damages could help pay for future medical bills, including for conditions that can arise for people with diabetes, so get started today with a no-cost case review.

We tell you about cash you can claim EVERY WEEK! Sign up for our free newsletter.

 

 

All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.

 

LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2013 Top Class Actions® LLC
Various Trademarks held by their respective owners.

Leave a Reply

Your email address will not be published. By submitting your comment and contact information, you agree to receive marketing emails from Top Class Actions regarding this and/or similar lawsuits or settlements, and/or to be contacted by an attorney or law firm to discuss the details of your potential case at no charge to you if you qualify. Required fields are marked *

Please note: Top Class Actions is not a settlement administrator or law firm. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury lawsuits and product liability lawsuits. Top Class Actions does not process claims and we cannot advise you on the status of any class action settlement claim. You must contact the settlement administrator or your attorney for any updates regarding your claim status, claim form or questions about when payments are expected to be mailed out.